Risperidone vs. haloperidol on reaction time, manual dexterity, and motor learning in treatment-resistant schizophrenia patients

Biological Psychiatry

Volumn 44, Issue 8, 1998, Pages 726-732

  Kern, Robert S ^a,c   Green, Michael F ^a,c   Marshall Jr , Barringer D ^b   Wirshing, William C ^a,c   Wirshing, Donna ^a,c   McGurk, Susan ^d   Marder, Stephen R ^a,c   Mintz, Jim ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA Dept Psychiat B   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

Haloperidol; Manual dexterity; Psychomotor speed; Reaction time; Risperidone; Schizophrenia

Indexed keywords

HALOPERIDOL; RISPERIDONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; DOUBLE-BLIND METHOD; DRUG RESISTANCE; FEMALE; HALOPERIDOL; HUMANS; LEARNING; MALE; MOTOR SKILLS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; REACTION TIME; RISPERIDONE; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0032532519     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00088-2     Document Type: Article

References (37)

1. Cancro R., Sutton S., Kerr J., Sugarman A. Reaction time and prognosis in acute schizophrenia. J Nerv Ment Dis. 153:1971;351-359.
2. Cassens G., Inglis A.K., Appelbaum P.S., Gutheil T.G. Neuroleptics Effects on neuropsychological function in chronic schizophrenic patients . Schizophr Bull. 16:1990;477-499.
3. Clare L., McKenna P.J., Mortimer A.M., Baddeley A.D. Memory in schizophrenia What is impaired and what is spared? Neuropsychologia. 31:1993;1225-1241.
4. Classen W., Laux G. Sensorimotor and cognitive performance of schizophrenic inpatients treated with haloperidol, flupenthixol, or clozapine. Pharmacopsychiatry. 21:1988;295-297.
5. Flowers K. Some frequency response characteristics of parkinsonism on pursuit tracking. Brain. 101:1978;19-34.
6. Gold J.M., Goldberg T.E., Kleinman J.E., Weinberger D.R. The impact of symptomatic state and pharmacological treatment on cognitive functioning of patients with schizophrenia and mood disorders. Mohr E., Brouwers P. Handbook of Clinical Trials The Neurobehavioral Approach . 1991;185-214 Swets & Zeitlinger, Amsterdam.
7. Goldberg T.E., Greenberg R.D., Griffin S.J., Gold J.M., Kleinman J.E., Pickar D., et al. The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry. 162:1993;43-48.
8. Goldberg T.E., Torrey E.F., Gold J.M., Ragland J.D., Bigelow L.B., Weinberger D.R. Learning and memory in monozygotic twins discordant for schizophrenia. Psychol Med. 23:1993;71-85.
9. Granholm E., Bartzokis G., Asarnow R.F., Marder S.R. Preliminary associations between motor procedural learning, basal ganglia T2 relaxation times, and tardive dyskinesia. Psychiatry Res. 50:1993;33-44.
10. Green M.F., Kern R.S., Williams O., McGurk S., Kee K.S. Procedural learning in schizophrenia Evidence from serial reaction time . Cogn Neuropsychiatry. 2:1997;123-134.
11. Green M.F., Marshall B.D. Jr, Wirshing W.C., Ames D., Marder S.R., McGurk S., et al. Does risperidone improve verbal working memory in treatment-resistant schizophrenia? Am J Psychiatry. 154:1997;799-804.
12. Heindel W.C., Salmon D.P., Shults C.W., Walicke P.A., Butters N. Neuropsychological evidence for multiple implicit memory systems A comparison of Alzheimer's, Huntington's, and Parkinson's disease patients . J Neurosci. 9:1989;582-587.
13. Hoff A.L., Faustman W.O., Wieneke M., Espinoza S., Costa M., Wolkowitz O., et al. The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment refractory state hospital schizophrenic inpatients. Neuropsychopharmacology. 15:1996;361-369.
14. Huston P., Shakow D., Riggs L. Studies of motor function in schizophrenia. II. Reaction time. J Gen Psychol. 16:1937;39-82.
15. Kane J., Honigfield G., Singer J., Meltzer H., Group C.C.S. Clozapine for the treatment-resistant schizophrenic A double-blind comparison with chlorpromazine . Arch Gen Psychiatry. 45:1988;789-796.
16. Kern R.S., Green M.F., Satz P., Wirshing W.C. Patterns of manual dominance in patients with neuroleptic-induced movement disorders. Biol Psychiatry. 30:1991;483-492.
17. Kern R.S., Green M.F., Wallace C.J. Declarative and procedural learning in schizophrenia A test of the integrity of divergent memory systems . Cogn Neuropsychiatry. 2:1997;39-50.
18. King D.J. The effect of neuroleptics on cognitive and psychomotor function. Br J Psychiatry. 157:1990;799-811.
19. King H.E. Psychomotor dysfunction in schizophrenia. Steinhauer S.R., Gruzelier J.H., Zubin J. Handbook of Schizophrenia Vol. 5. Neuropsychology, Psychophysiology and Information Processing . 1991;273-301 Elsevier Science Publishers, Amsterdam.
20. Knopman D.S., Nissen M.J. Implicit learning in patients with probable Alzheimer's disease. Neurology. 37:1987;784-788.
21. Kornetsky C., Pettit M., Wynne R.D., Evarts E.V. A comparison of the psychological effects of acute and chronic administration of chlorpromazine and secobarbital (quinalbarbitone) in schizophrenic patients. J Ment Sci. 105:1959;190-198.
22. Levin S., Yurgelun-Todd D., Craft S. Contributions of clinical neuropsychology to the study of schizophrenia. J Abnorm Psychol. 98:1989;341-356.
23. May P.R.A., Lee M.A., Bacon R.C. Quantitative assessment of neuroleptic-induced extrapyramidal symptoms Clinical and nonclinical approaches . Clin Neuropharmacol. 6:(suppl 1):1983;S35-S51.
24. Medalia A., Gold J., Mirriam A. The effects of neuroleptics on neuropsychological test results of schizophrenics. Arch Clin Neuropsychol. 3:1988;249-271.
25. Pearl D. Phenothiazine effects in chronic schizophrenia. J Clin Psychol. 18:1962;86-89.
26. Pugh L.A. Response time and electrodermal measures in chronic schizophrenia The effects of chlorpromazine . J Nerv Ment Dis. 146:1968;62-70.
27. Satz P., D'Elia L.F. Pin Test Manual. 1989;Psychological Assessment Resources, Odessa, FL.
28. Shakow D., Huston P. Studies of motor function in schizophrenia. I. Speed of tapping. J Gen Psychol. 15:1936;63-103.
29. Small I.F., Small J.G., Milstein V., Moore J.E. Neuropsychological observations with psychosis and somatic treatment Neuropsychological examinations of psychiatric patients . J Nerv Ment Dis. 155:1972;6-13.
30. Spitzer R.L., Williams J.B.W., Gibbon M., First M.B. Structured Clinical Interview for DSM-III-R, Patient Edition (SCID-P, Version 1.0). 1990;American Psychiatric Press, Washington, DC.
31. Spohn H.E., Strauss M.E. Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. J Abnorm Psychol. 98:1989;367-380.
32. Ventura J., Green M.F., Shaner A., Liberman R.P. Training and quality assurance with the Brief Psychiatric Rating Scale "The drift busters." Int J Methods Psychiatr Res. 3:1993;221-224.
33. Whitehead W.D., Thune L.E. The effects of chlorpromazine on learning in chronic psychotics. J Consult Psychol. 22:1958;379-383.
34. Wykes T., Dunn G. Cognitive deficit and the prediction of rehabilitation success in a chronic psychiatric group. Psychol Med. 22:1992;389-398.
35. Wykes T., Sturt E., Katz R. The prediction of rehabilitative success after three years The use of social, symptom and cognitive variables . Br J Psychiatry. 157:1990;865-870.
36. Zahn T.P., Carpenter W.T. Jr. Effects of short-term outcome and clinical improvement on reaction time in acute schizophrenia. J Psychiatr Res. 14:1978;59-68.
37. Zahn T.P., Pickar D., Haier R.J. Effects of clozapine, fluphenazine, and placebo on reaction time measures of attention and sensory dominance in schizophrenia. Schizophr Res. 13:1994;133-144.